{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:59:08Z","timestamp":1783573148676,"version":"3.55.0"},"reference-count":34,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus University","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004046","name":"Karen Elise Jensen Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Danish Lymphoma Group","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Fibroblast activation protein (FAP), a transmembrane serine protease expressed primarily in pathological conditions, plays a pivotal role in tumor progression. Despite extensive studies on FAP in solid tumors, its role in hematologic cancers, particularly lymphoid malignancies, remains underexplored. This study aimed to investigate the level and activity of soluble FAP (sFAP) in pre-therapeutic serum samples from 120 lymphoma patients. We measured sFAP serum levels using time-resolved immunofluorometric assay and sFAP activity with F\u00f6rster resonance energy transfer assay. In addition, immunohistochemistry was used to analyze intratumoral FAP expression in tissue biopsies from a subset of B-cell lymphoma patients (n = 34). Notably, the results revealed significantly reduced circulating sFAP levels (p = 0.002) and activity (p &lt; 0.001) in aggressive disease subtypes compared with indolent subtypes and healthy individuals. At the time of diagnosis, low sFAP activity correlated with inferior overall survival (both p &lt; 0.001) in patients with the aggressive entities, suggesting altered FAP functionality in these tumors. Interestingly, measuring intratumoral FAP levels revealed an inverse pattern, with diffuse large B-cell lymphoma showing higher tissue FAP localization compared with follicular lymphoma (p &lt; 0.001). These findings provide new insights into the biological and clinical significance of FAP in lymphoid malignancies, particularly highlighting the importance of sFAP activity as a potential prognostic marker in aggressive lymphoid malignancies.<\/jats:p>","DOI":"10.3390\/ijms262311248","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:59:46Z","timestamp":1763715586000},"page":"11248","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5706-3407","authenticated-orcid":false,"given":"Jonas Klejs","family":"Hemmingsen","sequence":"first","affiliation":[{"name":"Department of Hematology, Aarhus University Hospital, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-5183","authenticated-orcid":false,"given":"Marie Hairing","family":"Enemark","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aarhus University Hospital, 8210 Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Kathrine Nissen","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Medical\/Steno Aarhus Research Laboratory, Department of Clinical Medicine, Aarhus University, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4588-5607","authenticated-orcid":false,"given":"Emma Frasez","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aarhus University Hospital, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Lystlund","family":"Lauridsen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aarhus University Hospital, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Bondgaard","family":"L\u00f8hde","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aarhus University Hospital, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"d\u2019Amore","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aarhus University Hospital, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Jacques","family":"Hamilton-Dutoit","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aarhus University Hospital, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Bjerre","sequence":"additional","affiliation":[{"name":"Medical\/Steno Aarhus Research Laboratory, Department of Clinical Medicine, Aarhus University, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5089-3271","authenticated-orcid":false,"given":"Maja","family":"Ludvigsen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aarhus University Hospital, 8210 Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, 8210 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1021\/acsmedchemlett.9b00191","article-title":"Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP)","volume":"10","author":"Vliegen","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Xin, L., Gao, J., Zheng, Z., Chen, Y., Lv, S., Zhao, Z., Yu, C., Yang, X., and Zhang, R. (2021). Fibroblast Activation Protein-\u03b1 as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.648187"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Liu, F., Qi, L., Liu, B., Liu, J., Zhang, H., Che, D., Cao, J., Shen, J., Geng, J., and Bi, Y. (2015). Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116683"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Basalova, N., Alexandrushkina, N., Grigorieva, O., Kulebyakina, M., and Efimenko, A. (2023). Fibroblast Activation Protein Alpha (FAP\u03b1) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells?. Biomolecules, 13.","DOI":"10.3390\/biom13121718"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.abb.2006.11.006","article-title":"Effect of fibroblast activation protein and \u03b12-antiplasmin cleaving enzyme on collagen Types I, III, and IV","volume":"457","author":"Christiansen","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.18632\/aging.103261","article-title":"Altered expression of fibroblast activation protein-\u03b1 (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases","volume":"12","author":"Beitia","year":"2020","journal-title":"Aging"},{"key":"ref_9","first-page":"201","article-title":"Promotion of Cellular Growth and Motility Is Independent of Enzymatic Activity of Fibroblast Activation Protein-\u03b1","volume":"13","author":"Lv","year":"2016","journal-title":"Cancer Genom. Proteom."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"LeBleu, V.S., and Kalluri, R. (2018). A peek into cancer-associated fibroblasts: Origins, functions and translational impact. Dis. Model. Mech., 11.","DOI":"10.1242\/dmm.029447"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"117049","DOI":"10.1016\/j.lfs.2019.117049","article-title":"Stromal reprogramming: A target for tumor therapy","volume":"239","author":"Najafi","year":"2019","journal-title":"Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/prca.201300095","article-title":"Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy","volume":"8","author":"Hamson","year":"2014","journal-title":"Proteom.\u2014Clin. Appl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","article-title":"Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein","volume":"107","author":"Lee","year":"2006","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111738","DOI":"10.1016\/j.mce.2022.111738","article-title":"Sitagliptin reduces FAP-activity and increases intact FGF21 levels in patients with newly detected glucose abnormalities","volume":"556","author":"Pedersen","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.2006.05976.x","article-title":"Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival","volume":"133","author":"Ge","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4161\/cbt.29924","article-title":"Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through \u03b2-catenin signaling pathway","volume":"15","author":"Zi","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/or.2020.7874","article-title":"Expression and role of fibroblast activation protein \u03b1 in acute myeloid leukemia","volume":"45","author":"Mei","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/imr.12745","article-title":"Molecular pathogenesis of germinal center-derived B cell lymphomas","volume":"288","author":"Pasqualucci","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"30050","DOI":"10.18632\/oncotarget.16274","article-title":"Evaluation of the circulating level of fibroblast activation protein \u03b1 for diagnosis of esophageal squamous cell carcinoma","volume":"8","author":"Liao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2967\/jnumed.123.265530","article-title":"Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET\/CT and 18F-FDG PET\/CT","volume":"64","author":"Chen","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2967\/jnumed.121.262134","article-title":"Detecting Fibroblast Activation Proteins in Lymphoma Using 68Ga-FAPI PET\/CT","volume":"63","author":"Jin","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1589903","DOI":"10.3389\/fnume.2025.1589903","article-title":"The role of FAPI PET\/CT in patients with lymphoma: A systematic review","volume":"5","author":"Quartuccio","year":"2025","journal-title":"Front Nucl Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Guglielmo, P., Alongi, P., Baratto, L., Abenavoli, E., Buschiazzo, A., Celesti, G., Conte, M., Filice, R., Gorica, J., and Jonghi-Lavarini, L. (2023). Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature. Life, 13.","DOI":"10.3390\/life13091821"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","article-title":"Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion","volume":"303","author":"Zhang","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/ejh.13621","article-title":"Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies","volume":"107","author":"Mortensen","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"ref_29","first-page":"106","article-title":"Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After Treatment","volume":"105","author":"Dal","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2147\/OTT.S289337","article-title":"PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation","volume":"ume 14","author":"Enemark","year":"2021","journal-title":"OncoTargets Ther."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Enemark, M.B., Hybel, T.E., Madsen, C., Lauridsen, K.L., Honor\u00e9, B., Plesner, T.L., Hamilton-Dutoit, S., D\u2019amore, F., and Ludvigsen, M. (2022). Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients. Cancers, 14.","DOI":"10.3390\/cancers14051316"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1080\/0284186X.2021.1973093","article-title":"Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder","volume":"60","author":"Hybel","year":"2021","journal-title":"Acta Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1182\/bloodadvances.2023011299","article-title":"Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma","volume":"7","author":"Enemark","year":"2023","journal-title":"Blood Adv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41408-019-0197-5","article-title":"High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma","volume":"9","author":"Madsen","year":"2019","journal-title":"Blood Cancer J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11248\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T05:18:12Z","timestamp":1763875092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":34,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311248"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311248","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}